Rajeev Juneja Board of Director Membership

Home

Insights

Rajeev Juneja Board Membership

Last Updated on: Nov 22, 2024

About Rajeev Juneja

Mr. Rajeev Juneja serves as the Vice Chairman and Managing Director of Mankind Pharma Ltd. Under his leadership, the company has demonstrated significant growth, achieving a revenue of INR 2,607 crore in Q3 FY24, marking a 24.7% increase year-on-year.
His strategic focus on enhancing the domestic business, which constitutes over 90% of the company's sales, has led to a robust growth rate of 20% in Q3 FY24.
Mr. Juneja has been instrumental in steering the company towards a strong market position, maintaining a #4 rank in the Indian pharmaceutical market with a market share of 4.5%.
He has also emphasized the importance of chronic therapies, showcasing Mankind's outperformance in this segment.
His initiatives have supported a significant increase in both domestic and export revenues, with the latter witnessing a remarkable growth of 118% year-on-year in Q3 FY24.

List of Companies Associated with Rajeev Juneja

Company Name	Position Held	Market Cap	Sector	Date Of Appointment

Mankind Pharma Ltd

Vice Chairman & M.D.

103235.98

Pharmaceuticals

Mar, 2024

Company Name	Position Held
Mankind Pharma Ltd	Vice Chairman & M.D.

PRICE

<p>The current market price or CMP refers to the price of those companies associated with Rajeev Juneja at which the securities are trading in the share market.</p> <br> <h2>Current price in Over-the-counter costs:</h2> <p>The following current price of those companies associated with Rajeev Juneja depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC).</p> <br> <h2>Current Price in Bond Market: </h2> <p>The current price of a bond of those companies associated with Rajeev Juneja is determined by measuring the actual interest rate against the bid-related interest rate.</p> <br> <p>The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.</p>

Historical Share prices

* All values are in Rupees

Rajeev Juneja Sector Specific Experience

About Rajeev Juneja's work experience

Rajeev Juneja is currently a Vice Chairman & M.D. in Mankind Pharma Ltd (as of Mar 2024).
Rajeev Juneja is serving the company - Mankind Pharma Ltd at this position since 2024 for the last 1+ years.
Prior to becoming Vice Chairman & M.D., Rajeev Juneja was Chief Executive Officer of Mankind Pharma Ltd for 1 year in 2018.
Before becoming Chief Executive Officer, Rajeev Juneja was Wholetime Director of Mankind Pharma Ltd for 1 year in 2018.
Prior to becoming Wholetime Director, Rajeev Juneja was CEO of Mankind Pharma Ltd for 2 years from 2015 to 2016.

FAQ's related Rajeev Juneja

Who is Rajeev Juneja

Mr. Rajeev Juneja serves as the Vice Chairman and Managing Director of Mankind Pharma Ltd. Under his leadership, the company has demonstrated significant growth, achieving a revenue of INR 2,607 crore in Q3 FY24, marking a 24.7% increase year-on-year. His strategic focus on enhancing the domestic business, which constitutes over 90% of the company's sales, has led to a robust growth rate of 20% in Q3 FY24. Mr. Juneja has been instrumental in steering the company towards a strong market position, maintaining a #4 rank in the Indian pharmaceutical market with a market share of 4.5%. He has also emphasized the importance of chronic therapies, showcasing Mankind's outperformance in this segment. His initiatives have supported a significant increase in both domestic and export revenues, with the latter witnessing a remarkable growth of 118% year-on-year in Q3 FY24.

Which companies does Rajeev Juneja serve as a board member for?

Rajeev Juneja serves as a board member for: Mankind Pharma Ltd

What positions has Rajeev Juneja held in his/her career?

Throughout their career, Rajeev Juneja has held key positions such as Vice Chairman & M.D.,Chief Executive Officer,Wholetime Director,CEO,Whole-time director, contributing to the growth and success of each company.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*